196 related articles for article (PubMed ID: 30706232)
21. Analysis of 72 patients with colorectal high-grade neuroendocrine neoplasms from three Chinese hospitals.
Wang ZJ; An K; Li R; Shen W; Bao MD; Tao JH; Chen JN; Mei SW; Shen HY; Ma YB; Zhao FQ; Wei FZ; Liu Q
World J Gastroenterol; 2019 Sep; 25(34):5197-5209. PubMed ID: 31558867
[TBL] [Abstract][Full Text] [Related]
22. Survival impact of surgical resection of primary tumor in patients with stage IV colorectal cancer: results from a large population-based cohort study.
Ahmed S; Leis A; Fields A; Chandra-Kanthan S; Haider K; Alvi R; Reeder B; Pahwa P
Cancer; 2014 Mar; 120(5):683-91. PubMed ID: 24222180
[TBL] [Abstract][Full Text] [Related]
23. Effect of chemotherapy in patients with resected small-cell or large-cell neuroendocrine carcinoma.
Abedallaa N; Tremblay L; Baey C; Fabre D; Planchard D; Pignon JP; Guigay J; Pechoux CL; Soria JC; de Montpreville VT; Besse B
J Thorac Oncol; 2012 Jul; 7(7):1179-83. PubMed ID: 22617247
[TBL] [Abstract][Full Text] [Related]
24. Large Cell Neuroendocrine Tumor Size >3 cm Negatively Impacts Long-Term Outcomes After R0 Resection.
Cattoni M; Vallières E; Brown LM; Sarkeshik AA; Margaritora S; Siciliani A; Filosso PL; Guerrera F; Imperatori A; Rotolo N; Farjah F; Wandell G; Costas K; Mann C; Hubka M; Kaplan S; Farivar AS; Aye RW; Louie BE
World J Surg; 2019 Jul; 43(7):1712-1720. PubMed ID: 30783763
[TBL] [Abstract][Full Text] [Related]
25. Large cell neuroendocrine carcinoma of the lung: an aggressive disease potentially treatable with surgery.
Doddoli C; Barlesi F; Chetaille B; Garbe L; Thomas P; Giudicelli R; Fuentes P
Ann Thorac Surg; 2004 Apr; 77(4):1168-72. PubMed ID: 15063228
[TBL] [Abstract][Full Text] [Related]
26. Surgical treatment of extra-appendiceal colorectal neuroendocrine tumors.
Maryański J; Cyran-Chlebicka A; Szczepankiewicz B; Cebulski W; Słodkowski M; Wroński M
Pol Przegl Chir; 2018 May; 90(3):7-12. PubMed ID: 30015320
[TBL] [Abstract][Full Text] [Related]
27. Neuroendocrine carcinoma of the ampulla of Vater: a clinicopathologic evaluation.
Selvakumar E; Rajendran S; Balachandar TG; Kannan DG; Jeswanth S; Ravichandran P; Surendran R
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):422-5. PubMed ID: 18693180
[TBL] [Abstract][Full Text] [Related]
28. Treatment patterns and outcomes in goblet cell carcinoid tumors of the appendix.
Fields AC; Lu P; Enzinger A; Goldberg J; Irani J; Bleday R; Nash G; Melnitchouk N
J Surg Oncol; 2019 Dec; 120(7):1096-1101. PubMed ID: 31592538
[TBL] [Abstract][Full Text] [Related]
29. Distinct clinicopathologic features, genomic characteristics and survival of central and peripheral pulmonary large cell neuroendocrine carcinoma: From different origin cells?
Zhou F; Hou L; Ding T; Song Q; Chen X; Su C; Li W; Gao G; Ren S; Wu F; Fan J; Wu C; Zhang J; Zhou C
Lung Cancer; 2018 Feb; 116():30-37. PubMed ID: 29413048
[TBL] [Abstract][Full Text] [Related]
30. Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases.
Niitsu H; Hinoi T; Shimomura M; Egi H; Hattori M; Ishizaki Y; Adachi T; Saito Y; Miguchi M; Sawada H; Kochi M; Mukai S; Ohdan H
World J Surg Oncol; 2015 Apr; 13():162. PubMed ID: 25908502
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors and the role of adjuvant chemotherapy in post-curative surgery for Dukes B and C colon cancers and survival outcomes: a Malaysian experience.
Hassan AS; Naicker M; Yusof KH; Wan Ishak WZ
Asian Pac J Cancer Prev; 2015; 16(6):2237-43. PubMed ID: 25824744
[TBL] [Abstract][Full Text] [Related]
32. Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer.
Park HS; Jung M; Shin SJ; Heo SJ; Kim CG; Lee MG; Beom SH; Lee CY; Lee JG; Kim DJ; Ahn JB
Ann Surg Oncol; 2016 Mar; 23(3):928-35. PubMed ID: 26514121
[TBL] [Abstract][Full Text] [Related]
33. Predictors of survival after operation among patients with large cell neuroendocrine carcinoma of the lung.
Eichhorn F; Dienemann H; Muley T; Warth A; Hoffmann H
Ann Thorac Surg; 2015 Mar; 99(3):983-9. PubMed ID: 25596870
[TBL] [Abstract][Full Text] [Related]
34. Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease.
Cardona K; Donataccio D; Kingham TP; Allen PJ; DeMatteo RP; Fong Y; Jarnagin WR; Cercek A; Kemeny NE; D'Angelica MI
Ann Surg Oncol; 2014 Mar; 21(3):815-21. PubMed ID: 24242675
[TBL] [Abstract][Full Text] [Related]
35. Comparison between perioperative and postoperative chemotherapy after potentially curative hepatic resection for metastatic colorectal cancer.
Araujo R; Gonen M; Allen P; Blumgart L; DeMatteo R; Fong Y; Kemeny N; Jarnagin W; D'Angelica M
Ann Surg Oncol; 2013 Dec; 20(13):4312-21. PubMed ID: 23897009
[TBL] [Abstract][Full Text] [Related]
36. Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC.
Sluiter NR; Rovers KP; Salhi Y; Vlek SL; Coupé VMH; Verheul HMW; Kazemier G; de Hingh IHJT; Tuynman JB
Ann Surg Oncol; 2018 Aug; 25(8):2347-2356. PubMed ID: 29855834
[TBL] [Abstract][Full Text] [Related]
37. Management of brain metastases from large cell neuroendocrine carcinoma of the lung: improved outcomes with radiosurgery.
Wegner RE; Hasan S; Williamson RW; Finley G; Fuhrer R; Colonias A; Karlovits SM
Acta Oncol; 2019 Apr; 58(4):499-504. PubMed ID: 30732516
[TBL] [Abstract][Full Text] [Related]
38. Surgical resection for clinical stage I high-grade neuroendocrine carcinoma of the lung.
Mochizuki E; Matsuura S; Oishi K; Miyashita K; Ichijyo K; Furukawa S; Nagaoka M; Mikura S; Tsukui M; Koshimizu N; Sakurai S; Asada K; Shirai T
World J Surg Oncol; 2018 Feb; 16(1):33. PubMed ID: 29454358
[TBL] [Abstract][Full Text] [Related]
39. Comparison of clinicopathological characteristics and prognosis between early and late recurrence after curative surgery for colorectal cancer.
Lan YT; Chang SC; Yang SH; Lin CC; Wang HS; Jiang JK; Chen WS; Lin TC; Chiou SH; Lin JK
Am J Surg; 2014 Jun; 207(6):922-30. PubMed ID: 24355407
[TBL] [Abstract][Full Text] [Related]
40. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
